ZHANG, Xiaokui,張小葵,HARIRI, Robert, J. J,羅伯特‧,VOSKINARIAN-BERSE, Vanessa -,‧哈黎裡,KANG, Lin,瓦內薩‧沃斯基納裡安-貝爾斯,LAW, Eric,康琳,ABBOT, Stewart,埃裡克‧勞,斯圖爾特‧阿博特
申请号：
HK16106559.2
公开号：
HK1218515A
申请日:
2016.06.07
申请国别(地区):
HK
年份:
2017
代理人:
摘要：
Provided herein are placental perfusate, placental perfusate cells, placenta-derived intermediate natural killer cells, combined natural killer cells from placenta and umbilical cord blood, and combinations thereof. Also provided herein are compositions comprising the same, and methods of using placental perfusate, placental perfusate cells, placenta-derived intermediate natural killer cells, and combined natural killer cells and combinations thereof, to suppress the growth or proliferation of tumor cells, cancer cells, and the like, and to treat individuals having tumor cells. Also provided herein are methods of treating an individual having a tumor or graft-versus-host disease with placental perfusate, placental perfusate-derived cells, natural killer cells from placenta, e.g., from placental perfusate, and/or combined natural killer cells comprising natural killer cells from placenta, e.g., from placental perfusate, and umbilical cord blood.
